Sector portfolio · Government fund · United States
National Science Foundation's Pharma portfolio
National Science Foundation has backed 17 Pharma startups in rounds we track, $22M between them, shown by the stage each has reached. The best-funded is Novome Biotechnologies.
National Science Foundation's whole portfolioNational Science Foundation's profile
Funding by segment
- Stage not reported$9.2M12
- Pre-seed and seed$13M5
Where they are based
- United States13$19M
United StatesFounded
Total raised
- Under $1M10
- $1M to $10M7
- $10M to $50M0
- $50M to $250M0
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 17 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States13
Startups by country, 1 country in all.
Segment by segment
Stage not reported
12 startups · $9.2M raised
Snapdragon ChemistrySnapdragon Chemistry focus on developing practical manufacturing solutions for challenging chemical transformations.-$1.5M
Ground Fluor PharmaceuticalsGround Fluor Pharmaceuticals develops new imaging agents for use in diagnosis and management of disease, and to help other companies.-$1.3M
XhemeA Best-in-Class Cell-Health Engineering Platform.United States$1.2M
CytocyberneticsCytocybernetics is a Biotechnology which specializes in cellular electrophysiologyUnited States$1.0M
OculogenexOculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders.United States$1.0M- CCytoMagCytoMag offers microfluidic systems for rapid cell isolation and analysis.-$922K
Core Quantum TechnologiesCore Quantum Technologies engages in illuminating cell biology and pathology.United States$900K- FBFelix BiotechnologyFelix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.United States$314K
Pre-seed and seed
5 startups · $13M raised
BioSapienBioSapien Inc.United States$8.0M
inSomaBioInSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.United States$4.6M
SequegenicsSequegenics is a fully automated cloud platform to detect Structural Variants and other complex types of variation.United States$500K
Macromoltek IncMacromoltek Inc.United States$120K
Glauconix BiosciencesGlauconix Biosciences is a pharmaceutical research company that uses technology to lower the cost of ophthalmic drug development.-$100K
How this map is made. Every startup here works in Pharma and has raised money in a round we track that names National Science Foundation as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like National Science Foundation?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.